Autonomix Medical, Inc. (AMIX)
About Autonomix Medical, Inc.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $0
- Net income
- -$16.7M
- Total assets
- $7.6M
- Market cap
- $4.7M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $17.0M
- Operating income
- -$17.0M
- Income tax
- $0
- Net income
- -$16.7M
- EPS (basic)
- $-2.32
Balance sheet
- Total assets
- $7.6M
- Current assets
- $7.6M
- Total liabilities
- $1.7M
- Current liabilities
- $1.7M
- Shareholders’ equity
- $5.9M
Cash flow
- Operating cash flow
- -$12.3M
- Investing cash flow
- -$10.0K
- Financing cash flow
- $10.2M
- Net cash flow
- -$2.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.7M
- Shares outstanding
- 1.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 29, 2024
Autonomix Medical, Inc. (AMIX) Stock Price
- Reported a net loss of $16.7M in FY2026.
- Trading 89% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Autonomix Medical, Inc..
Write a review
News about Autonomix Medical, Inc.
News & sentiment via Polygon.io
Autonomix Medical, Inc.: frequently asked questions
Is Autonomix Medical, Inc. an American company?
Autonomix Medical, Inc. is a US-based company headquartered in The Woodlands, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Autonomix Medical, Inc. headquartered?
Autonomix Medical, Inc. is headquartered in The Woodlands, Texas, United States.
Is Autonomix Medical, Inc. publicly traded?
Yes — Autonomix Medical, Inc. is a publicly traded company. Its stock trades under the ticker symbol AMIX on the NASDAQ.
What does Autonomix Medical, Inc. do?
Autonomix Medical, Inc. is an American Medical Devices company in the Health & Beauty sector.